Education
About Us
Working with TipRanks
Follow Us
Disc Medicine (IRON)
NASDAQ:IRON
Total Valuation
Disc Medicine has a market cap or net worth of $1.80B. The enterprise value is -$172.60M.
Market Cap$1.80B
Enterprise Value-$172.60M
Share Statistics
Disc Medicine has 34,634,296 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,634,296
Owned by Insiders26.59%
Owned by Institutions<0.01%
Financial Efficiency
Disc Medicine’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -27.48%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-27.48%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee0.00
Profits Per Employee-1.16M
Employee Count94
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Disc Medicine is -16.00. Disc Medicine’s PEG ratio is >-0.01.
PE Ratio-16.00
PS Ratio0.00
PB Ratio0.12
Price to Fair Value3.95
Price to FCF-0.49
Price to Operating Cash Flow-0.49
PEG Ratio>-0.01
Income Statement
In the last 12 months, Disc Medicine had revenue of 0.00 and earned -109.36M in profits. Earnings per share was -3.96.
Revenue0.00
Gross Profit-156.00K
Operating Income-129.72M
Pretax Income-109.00M
Net Income-109.36M
EBITDA-108.27M
Earnings Per Share (EPS)-3.96
Cash Flow
In the last 12 months, operating cash flow was -101.70M and capital expenditures -1.29M, giving a free cash flow of -102.99M billion.
Operating Cash Flow-101.70M
Free Cash Flow-102.99M
Free Cash Flow per Share-2.97
Dividends & Yields
Disc Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.69
52-Week Price Change21.43%
50-Day Moving Average46.33
200-Day Moving Average53.01
Relative Strength Index (RSI)52.90
Average Volume (3m)377.99K
Important Dates
Disc Medicine upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend Date―
Financial Position
Disc Medicine as a current ratio of 21.17, with Debt / Equity ratio of 0.76%
Current Ratio21.17
Quick Ratio21.17
Debt to Market Cap0.02
Net Debt to EBITDA1.50
Interest Coverage Ratio-226.78
Taxes
In the past 12 months, Disc Medicine has paid 355.00K in taxes.
Income Tax355.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Disc Medicine EV to EBITDA ratio is -14.66, with an EV/FCF ratio of -16.81.
EV to Sales0.00
EV to EBITDA-14.66
EV to Free Cash Flow-16.81
EV to Operating Cash Flow-16.90
Balance Sheet
Disc Medicine has $694.66M in cash and marketable securities with $30.64M in debt, giving a net cash position of -$664.02M billion.
Cash & Marketable Securities$694.66M
Total Debt$30.64M
Net Cash-$664.02M
Net Cash Per Share-$19.17
Tangible Book Value Per Share$16.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Disc Medicine is $93.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$93.50
Price Target Upside86.66% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast―
EPS Growth Forecast-14.19%